Tejnaksh Healthcare Ltd Financials
Company Logo

Tejnaksh Healthcare Ltd Financial Statement

Tejnaksh Healthcare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue2.06
Operating Expense1.06
Net Profit0.56
Net Profit Margin27.18
Earning Per Share0.31
EBIDTA1.07
Effective Tax Rate13.00
Invest in Tejnaksh Healthcare Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Tejnaksh Healthcare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual7.34
Operating Expenses Annual4.20
Operating Profit Annual3.37
Interest Annual0.61
Depreciation0.79
Net Profit Annual1.38
Tax Annual0.58

Tejnaksh Healthcare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.66
Cash Flow from Operations4.15
Cash Flow from Investing-1.08
Cash Flow from Financing-2.31
Cash Flow at the End1.41

Tejnaksh Healthcare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)47.81
PBIT Margin (%)38.08
PBT Margin (%)-16.30
Net PROFIT Margin (%)22.02
Return On Networth / Equity (%)8.28
Return On Networth /Employed (%)11.12
Return On Assets (%)6.39
Total Debt / Equity (X)0.26
Asset Turnover Ratio (%)0.29

Tejnaksh Healthcare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual23.21
Total Current Assets Annual5.46
Non Current Assets Annual24.66
Total Shareholders Funds Annual22.78
Total Assets Annual30.11

Tejnaksh Healthcare Ltd Earning Calls

EPS (INR)

Expected

0.31

Reported

0.31

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by -3.33%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 22, 2024, Tejnaksh Healthcare Ltd has a market capitalization of 47.05 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Tejnaksh Healthcare Ltd is debt-free with a debt-to-equity ratio of 0.18.
In FY 2023 , Tejnaksh Healthcare Ltd recorded a total revenue of approximately 8.22 Cr marking a significant milestone in the company's financial performance.
Tejnaksh Healthcare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.6% and 0.0% annually, respectively..
Tejnaksh Healthcare Ltd's current PE ratio is 25.99.
Tejnaksh Healthcare Ltd's ROCE averaged 11.9% from the FY ending March 2022 to 2024, with a median of 11.4%. It peaked at 14.8% in March 2022, reflecting strong capital efficiency over the period..
Tejnaksh Healthcare Ltd's latest EBIT is Rs. 3.12 Cr, surpassing the average EBIT of Rs. 3.18 Cr over the 5 years..